查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1868808

切除术市场按适应症、手术入路、手术类型和最终用户划分－2025-2032年全球预测

Colectomy Procedures Market by Indication, Surgical Approach, Procedure Type, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，切除术市场将成长至 28.6 亿美元，复合年增长率为 5.58%。

关键市场统计数据
基准年 2024 18.5亿美元
预计年份：2025年 19.5亿美元
预测年份 2032 28.6亿美元
复合年增长率 (%) 5.58%

对当前切除术护理趋势的权威阐述，将临床实践的演变、技术应用和组织决策动态联繫起来。

本执行摘要全面检验直肠切除术。它整合了影响医疗实践和采购的临床趋势、不断发展的技术以及相关人员。分析重点在于外科技术进步、手术全期护理路径和医疗设备创新如何与医务人员的工作流程和患者期望相互作用，从而影响临床医生和医疗机构层面的决策。

切除术治疗领域发生了重大转变，这主要得益于微创技术的应用、流程的重新设计以及以结果为导向的临床实践的发展。

切除术的手术流程正经历着变革性的转变，这主要得益于技术进步、临床指南的不断完善以及对基于价值的治疗结果日益重视。微创手术的应用范围不断扩大，这得益于器械和视觉化技术的改进，以及围手术全期流程的深度整合，尤其着重于加快病患復原和减少资源消耗。与此临床进展相呼应，机器人辅助技术也从最初的小众应用发展成为某些复杂切除术的首选方案，这促使人们重新思考培训课程和资本投资规划。

美国近期关税调整对结肠切除相关技术的筹资策略、供应链韧性与供应商关係的影响

美国近期关税政策的调整，为参与切除术相关手术器械、机器人平台和一次性医疗器材组件采购的相关人员带来了更多复杂性。这些政策变化正在影响医院系统和门诊网路的采购週期、供应商合约策略以及资本规划讨论。拥有集中采购团队的医疗机构正优先考虑合约重新谈判和整体拥有成本评估，以减轻政策调整对采购的直接影响，同时确保临床能够获得优先技术。

一种基于细分的观点，将适应症、手术细节、手术方法和护理环境与器械、训练和临床路径的实际意义联繫起来。

细分市场洞察揭示了适应症、手术方法、手术类型和最终用户环境等方面的不同临床和商业性路径，每种路径都对技术应用和医疗服务有独特的影响。基于适应症，我们分析了癌症、克隆氏症、憩室病和溃疡性大肠炎的市场，并根据此分布确定了临床优先事项。肿瘤切除术需要遵循肿瘤学原则，并在适用情况下进行淋巴结清除。发炎性肠道疾病通常需要复杂的决策来维持肠道长度并控制慢性发炎变化，而憩室病和急性併发症则强调快速控制病情和减轻併发症。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 快速采用机器人辅助单孔结肠切除系统，实现精准切除
  • 整合人工智慧驱动的术中影像技术以指导靶向切除
  • 透过完善术后復健通讯协定来缩短住院时间
  • 微创自然腔道内视镜手术（NOTES）的采用率迅速提高
  • 切除术以生物可吸收缝合线加固材料的研发
  • 利用远端医疗监测增加门诊结肠切除术项目
  • 加大对切除术患者个别化手术计画软体的投资
  • 亚洲新兴市场对携带式腹腔镜设备的需求不断增长

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 依适应症分類的切除术市场

  • 癌症
  • 克隆氏症
  • 憩室病
  • 溃疡性大肠炎

9. 依手术方式切除术市场

  • 微创手术
    • 腹腔镜
    • 机器人辅助
  • 开放性手术

10. 依手术类型分類的切除术市场

  • 部分切除术
    • 左半切除术
    • 右半切除术
    • 切除术
    • 横结肠切除术
  • 切除术
  • 全切除术

第十一章 以最终用户分類的切除术市场

  • 门诊手术中心
  • 医院外科中心
  • 门诊部

12. 各地区切除术市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章切除术市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

14. 各国切除术市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Johnson & Johnson
    • Medtronic plc
    • B. Braun Melsungen AG
    • Stryker Corporation
    • Intuitive Surgical, Inc.
    • Boston Scientific Corporation
    • ConMed Corporation
    • Olympus Corporation
    • Smith & Nephew plc
    • Cook Medical LLC
Product Code: MRR-6A132FD32B20

The Colectomy Procedures Market is projected to grow by USD 2.86 billion at a CAGR of 5.58% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 1.85 billion
Estimated Year [2025] USD 1.95 billion
Forecast Year [2032] USD 2.86 billion
CAGR (%) 5.58%

An authoritative orientation to current developments in colectomy care that bridges clinical practice evolution, technology adoption, and institutional decision-making dynamics

This executive summary introduces a comprehensive examination of colectomy procedures, synthesizing clinical trends, procedural evolution, and stakeholder dynamics that shape practice and procurement across care settings. The analysis centers on how advances in surgical technique, perioperative care pathways, and device innovation intersect with provider workflows and patient expectations to influence decision-making at the clinician and organizational level.

The objective is to provide a succinct yet systematic narrative that helps clinical leaders, hospital administrators, device innovators, and policy stakeholders navigate an increasingly complex landscape. Through evidence-informed observations and cross-disciplinary interpretation, the summary highlights points of inflection where clinical practice and industry strategy converge, framing actionable implications without prescriptive recommendations that require institution-level validation.

Readers will find an integrated perspective that connects clinical indications and procedural approaches to end-user environments and regional dynamics. This introduction sets the stage for deeper sections that analyze transformative shifts, tariff-related impacts, segmentation-derived insights, regional variation, company-level dynamics, recommended actions, and the methodology underpinning the findings.

Key inflection points in colectomy care driven by the convergence of minimally invasive technologies, operational redesign, and evolving outcome-focused clinical practice

The landscape of colectomy procedures is undergoing transformative shifts driven by technological refinement, evolving clinical guidelines, and a growing emphasis on value-based outcomes. Minimally invasive approaches have continued to expand their clinical footprint, not only because of improvements in instrumentation and visualization but also due to deeper integration of perioperative pathways that emphasize early recovery and reduced resource utilization. Alongside this clinical momentum, robotic assistance has matured from niche application to a prominent option for selected complex resections, prompting reassessment of training curricula and capital planning.

Concurrently, patient expectations and payer frameworks are reshaping how care is delivered. Enhanced recovery protocols, outpatient-facing pathways, and same-day surgery feasibility are prompting institutions to redesign admission, discharge, and follow-up processes to optimize throughput while maintaining safety. These operational shifts are aligned with efforts to measure outcomes that matter to patients, including functional recovery and quality-of-life metrics, which in turn influence procedural selection and device adoption.

Finally, the interplay between technological innovation and workforce readiness is redefining competency models for colorectal surgery. Simulation, modular credentialing, and multidisciplinary team integration are emerging as practical enablers for safely expanding minimally invasive and robotic programs. This confluence of clinical, operational, and educational trends marks a departure from incremental change toward coordinated transformation across the care continuum.

How recent tariff adjustments in the United States are reshaping procurement strategies, supply chain resilience, and vendor relationships for colectomy-related technologies

In the United States, recent tariff policy adjustments have introduced an additional layer of complexity for stakeholders involved in procuring surgical instrumentation, robotic platforms, and disposable device components relevant to colectomy procedures. These policy changes have influenced procurement cycles, vendor contracting strategies, and capital planning conversations within hospital systems and ambulatory networks. Institutions with centralized purchasing teams have prioritized contract renegotiation and total-cost-of-ownership evaluations to mitigate the immediate procurement effects while preserving clinical access to preferred technologies.

The cumulative impact has been moderated by several adaptive responses. Clinical teams and supply chain leaders have collaborated more closely to identify clinically equivalent device alternatives, optimize inventory management, and stagger capital acquisition to reduce exposure to tariff-driven price volatility. Additionally, manufacturers and distributors have taken steps to revise commercial terms, localize certain supply chain nodes where feasible, and provide bundled service models that emphasize predictable lifecycle costs and training support.

Looking ahead, sustained tariff-driven pressures are accelerating consideration of regional sourcing strategies and device standardization where clinically appropriate. Stakeholders are balancing the need to maintain advances in minimally invasive and robotic capabilities against the financial imperative to control procedural costs, thereby reinforcing the importance of comprehensive procurement frameworks that align clinical priorities with fiscal stewardship.

Segmentation-driven perspectives that map indications, procedural nuances, surgical approaches, and care settings to practical implications for devices, training, and clinical pathways

Segmentation insights reveal differentiated clinical and commercial pathways across indications, surgical approaches, procedure types, and end-user environments, each carrying distinct implications for technology adoption and care delivery. Based on Indication, market is studied across Cancer, Crohn's Disease, Diverticular Disease, and Ulcerative Colitis, and this distribution informs clinical priorities: oncologic resections demand oncologic principles and lymphadenectomy where applicable, inflammatory bowel disease often requires complex decision-making around preserving bowel length and managing chronic inflammatory changes, while diverticular disease and acute complications emphasize timely source control and complication mitigation.

Based on Surgical Approach, market is studied across Minimally Invasive and Open Surgery. The Minimally Invasive is further studied across Laparoscopic and Robotic Assisted, and these distinctions shape resource needs and training trajectories. Laparoscopic techniques remain foundational for many resections, offering reproducible outcomes with established instrumentation, whereas robotic assistance is leveraged for ergonomic advantages, three-dimensional visualization, and articulated instrument control in anatomically constrained or technically demanding situations. Open surgery retains a vital role for complex emergencies, multi-visceral resections, and scenarios where tactile feedback and rapid exposure are priorities.

Based on Procedure Type, market is studied across Partial Colectomy, Proctocolectomy, and Total Colectomy. The Partial Colectomy is further studied across Left Hemicolectomy, Right Hemicolectomy, Sigmoid Colectomy, and Transverse Hemicolectomy, and this granular typology aligns with variations in operative time, perioperative pathways, and device utilization. Different resection types impose distinct requirements for anastomotic technique, specimen extraction methods, and risk mitigation strategies for complications such as anastomotic leak and postoperative ileus.

Based on End User, market is studied across Ambulatory Surgical Centers, Hospital Surgical Centers, and Outpatient Clinics, and these settings influence workflow design, capital allocation, and care pathway configuration. Ambulatory surgical centers and outpatient clinics are increasingly significant for streamlined procedures and recovery-focused pathways, while hospital surgical centers remain central for complex resections, thoracoabdominal approaches, and high-acuity perioperative management. Understanding these segmentation layers enables stakeholders to tailor training, device bundles, and service models to the clinical and operational realities of each setting.

A comparative regional analysis of practice evolution, capacity expansion, and procurement dynamics across the Americas, Europe, Middle East & Africa, and Asia-Pacific

Regional dynamics exert tangible influence on clinical practice models, reimbursement frameworks, and the logistics of device deployment, yielding distinctive patterns across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, integrated health systems and a competitive private sector have driven investment in minimally invasive and robotic capacities, coupled with attention to perioperative efficiency and patient experience. Providers in this region frequently engage in centralized purchasing discussions and value-based pilot programs that shape device selection and service contracting models.

Europe, Middle East & Africa presents a heterogeneous picture where national health system structures, regulatory environments, and workforce distribution result in varied adoption rates. In many countries within this broad region, constrained capital allocation and differing reimbursement incentives emphasize cost-effectiveness and regional centers of excellence. Policymakers and providers often focus on standardizing perioperative care bundles to ensure consistent outcomes across diverse health settings.

Asia-Pacific exhibits rapid capacity expansion in tertiary centers and growing interest in advanced surgical platforms, driven by demographic trends and investment in specialized training. This region balances aggressive technology adoption in urban centers with pragmatic pathways to scale minimally invasive techniques in community hospitals. Across all regions, cross-border collaboration, international training programs, and remote proctoring are facilitating skill transfer and helping harmonize clinical standards despite differing local constraints.

How competitive differentiation, integrated service offerings, and evidence-focused commercial models are redefining company strategies across the colectomy procedural ecosystem

Company-level dynamics within the colectomy ecosystem reveal a competitive environment shaped by product differentiation, service models, and partnership strategies. Leading device manufacturers are prioritizing systems integration, evidence generation, and surgeon-focused support to differentiate their offerings. This includes investments in modular instrumentation, single-use options optimized for workflow, and digital capabilities that support perioperative planning and outcome tracking.

Commercial strategies increasingly emphasize bundled solutions that combine hardware, disposables, training, and service commitments to reduce friction in adoption decisions. Manufacturers and distributors are also experimenting with outcomes-linked contracting and training-as-a-service models to demonstrate value beyond unit sales. Collaborative arrangements between technology providers and clinical centers support iterative product refinement and generate real-world evidence that informs clinical guidelines and payer conversations.

Finally, new entrants and niche innovators are focusing on unmet procedural pain points such as ergonomic enhancements, cost-effective disposable technologies, and tools that streamline anastomosis or specimen extraction. These focused innovations complement broader platform strategies and create pathways for targeted partnerships or licensing arrangements with established players to accelerate market access and clinical validation.

Actionable strategic moves for providers and industry stakeholders to accelerate safe adoption, control costs, and align clinical outcomes with commercial frameworks

Industry leaders can translate the observed trends into concrete initiatives that align clinical quality with operational and commercial objectives. First, prioritize investment in clinician training programs that accelerate safe adoption of minimally invasive and robotic-assisted techniques while embedding enhanced recovery principles to improve throughput and patient outcomes. Structured proctoring, simulation, and competency-based credentialing will reduce variability and enable predictable program expansion.

Second, strengthen cross-functional alignment between clinical leadership and supply chain teams to implement total-cost-of-care evaluations when selecting devices and platforms. Negotiated service-level agreements, transparent lifecycle costing, and clinically informed standardization can preserve access to advanced technologies while containing procedural expenditure. Third, explore flexible commercial arrangements with technology providers, such as bundled procurement, subscription models for instrumentation, and outcomes-linked contracts, to align incentives across stakeholders and reduce capital barriers to adoption.

Finally, accelerate data-driven quality programs that tie procedural choices to patient-reported outcomes and complication metrics. Investing in interoperable data capture and analytics enables continuous improvement, supports payer conversations, and differentiates centers of excellence. These pragmatic steps will help institutions balance clinical innovation with fiscal responsibility and position organizations to respond adaptively to ongoing market and policy shifts.

A mixed-methods research framework integrating clinical evidence, stakeholder interviews, and device performance insights to ensure balanced, practice-oriented conclusions

The research underpinning this executive summary synthesizes peer-reviewed clinical literature, guideline statements, procedural registries, device technical documentation, and interviews with clinical and supply chain leaders across multiple regions. A mixed-methods approach combined qualitative interviews with thematic analysis to surface practical barriers and enablers, while structured reviews of clinical evidence and device characteristics provided technical context for procedural and training implications.

Primary inputs included consultations with practicing colorectal and general surgeons, perioperative nursing leaders, surgical program directors, and hospital procurement professionals. These engagements were used to validate observations about workflow, training needs, device preferences, and the operational impacts of tariff policy adjustments. Secondary sources comprised guideline summaries, published comparative effectiveness assessments, and device labeling and performance specifications to ensure clinical fidelity.

Synthesis prioritized triangulation across evidence streams, favoring consistency of observation and corroboration by multiple stakeholder types. Where perspectives diverged, the analysis highlighted conditional factors and contextual drivers rather than asserting universal conclusions. This methodology ensures that the findings are grounded in clinical practice realities while transparently reflecting areas that require institution-level interpretation.

Synthesis of clinical, operational, and commercial imperatives that define strategic priorities for institutions navigating the evolving colectomy landscape

In conclusion, colectomy procedures are at a strategic crossroads where clinical innovation, operational redesign, and commercial dynamics intersect to create both opportunities and challenges for providers and industry partners. Minimally invasive and robotic-assisted techniques continue to advance clinical capability, while market and policy pressures underscore the importance of procurement agility and cost-conscious adoption strategies. The interplay of indication-specific requirements, procedural heterogeneity, and end-user environments necessitates tailored approaches that respect clinical nuance while enabling scalable implementation.

Organizations that invest in competency-based training, cross-functional procurement frameworks, and data-enabled quality programs will be best positioned to reconcile clinical aspirations with economic realities. Moreover, regional differences in capacity and reimbursement call for differentiated market and operational strategies that reflect local constraints and growth trajectories. Ultimately, success will hinge on collaborative models that align clinician priorities, supply chain rigor, and vendor commitments to deliver predictable patient outcomes and sustainable programmatic growth.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rapid adoption of robotic-assisted single-port colectomy systems for precision
  • 5.2. Integration of AI-driven intraoperative imaging to guide targeted resections
  • 5.3. Expansion of enhanced recovery after surgery protocols reducing hospital stay
  • 5.4. Surge in minimally invasive natural orifice transluminal endoscopic surgery adoption
  • 5.5. Development of bioresorbable staple line reinforcement materials in colectomies
  • 5.6. Increasing outpatient colectomy programs enabled by telehealth monitoring
  • 5.7. Rising investment in patient-specific surgical planning software for colectomy
  • 5.8. Growing demand for portable laparoscopic devices in emerging Asian markets

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Colectomy Procedures Market, by Indication

  • 8.1. Cancer
  • 8.2. Crohn's Disease
  • 8.3. Diverticular Disease
  • 8.4. Ulcerative Colitis

9. Colectomy Procedures Market, by Surgical Approach

  • 9.1. Minimally Invasive
    • 9.1.1. Laparoscopic
    • 9.1.2. Robotic Assisted
  • 9.2. Open Surgery

10. Colectomy Procedures Market, by Procedure Type

  • 10.1. Partial Colectomy
    • 10.1.1. Left Hemicolectomy
    • 10.1.2. Right Hemicolectomy
    • 10.1.3. Sigmoid Colectomy
    • 10.1.4. Transverse Hemicolectomy
  • 10.2. Proctocolectomy
  • 10.3. Total Colectomy

11. Colectomy Procedures Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Hospital Surgical Centers
  • 11.3. Outpatient Clinics

12. Colectomy Procedures Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Colectomy Procedures Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Colectomy Procedures Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Johnson & Johnson
    • 15.3.2. Medtronic plc
    • 15.3.3. B. Braun Melsungen AG
    • 15.3.4. Stryker Corporation
    • 15.3.5. Intuitive Surgical, Inc.
    • 15.3.6. Boston Scientific Corporation
    • 15.3.7. ConMed Corporation
    • 15.3.8. Olympus Corporation
    • 15.3.9. Smith & Nephew plc
    • 15.3.10. Cook Medical LLC

LIST OF FIGURES

  • FIGURE 1. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY INDICATION, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY SURGICAL APPROACH, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY SURGICAL APPROACH, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS COLECTOMY PROCEDURES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA COLECTOMY PROCEDURES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA COLECTOMY PROCEDURES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA COLECTOMY PROCEDURES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE COLECTOMY PROCEDURES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST COLECTOMY PROCEDURES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA COLECTOMY PROCEDURES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC COLECTOMY PROCEDURES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN COLECTOMY PROCEDURES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC COLECTOMY PROCEDURES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION COLECTOMY PROCEDURES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS COLECTOMY PROCEDURES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 COLECTOMY PROCEDURES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO COLECTOMY PROCEDURES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. COLECTOMY PROCEDURES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. COLECTOMY PROCEDURES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. COLECTOMY PROCEDURES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY CANCER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY CANCER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY CANCER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY CANCER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY CANCER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY CANCER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY CROHN'S DISEASE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY CROHN'S DISEASE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY CROHN'S DISEASE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY CROHN'S DISEASE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY CROHN'S DISEASE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY CROHN'S DISEASE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY DIVERTICULAR DISEASE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY DIVERTICULAR DISEASE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY DIVERTICULAR DISEASE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY DIVERTICULAR DISEASE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY DIVERTICULAR DISEASE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY DIVERTICULAR DISEASE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY ULCERATIVE COLITIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY ULCERATIVE COLITIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY ULCERATIVE COLITIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY ULCERATIVE COLITIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY ULCERATIVE COLITIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY ULCERATIVE COLITIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY SURGICAL APPROACH, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY SURGICAL APPROACH, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY LAPAROSCOPIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY LAPAROSCOPIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY LAPAROSCOPIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY LAPAROSCOPIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY LAPAROSCOPIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY LAPAROSCOPIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY ROBOTIC ASSISTED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY ROBOTIC ASSISTED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY ROBOTIC ASSISTED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY ROBOTIC ASSISTED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY ROBOTIC ASSISTED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY ROBOTIC ASSISTED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY OPEN SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY OPEN SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY OPEN SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY OPEN SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY OPEN SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY OPEN SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY PARTIAL COLECTOMY, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY PARTIAL COLECTOMY, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY PARTIAL COLECTOMY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY PARTIAL COLECTOMY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY PARTIAL COLECTOMY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY PARTIAL COLECTOMY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY PARTIAL COLECTOMY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY PARTIAL COLECTOMY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY LEFT HEMICOLECTOMY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY LEFT HEMICOLECTOMY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY LEFT HEMICOLECTOMY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY LEFT HEMICOLECTOMY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY LEFT HEMICOLECTOMY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY LEFT HEMICOLECTOMY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY RIGHT HEMICOLECTOMY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY RIGHT HEMICOLECTOMY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY RIGHT HEMICOLECTOMY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY RIGHT HEMICOLECTOMY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY RIGHT HEMICOLECTOMY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY RIGHT HEMICOLECTOMY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY SIGMOID COLECTOMY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY SIGMOID COLECTOMY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY SIGMOID COLECTOMY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY SIGMOID COLECTOMY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY SIGMOID COLECTOMY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY SIGMOID COLECTOMY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY TRANSVERSE HEMICOLECTOMY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY TRANSVERSE HEMICOLECTOMY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY TRANSVERSE HEMICOLECTOMY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY TRANSVERSE HEMICOLECTOMY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY TRANSVERSE HEMICOLECTOMY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY TRANSVERSE HEMICOLECTOMY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY PROCTOCOLECTOMY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY PROCTOCOLECTOMY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY PROCTOCOLECTOMY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY PROCTOCOLECTOMY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY PROCTOCOLECTOMY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY PROCTOCOLECTOMY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY TOTAL COLECTOMY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY TOTAL COLECTOMY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY TOTAL COLECTOMY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY TOTAL COLECTOMY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY TOTAL COLECTOMY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY TOTAL COLECTOMY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY HOSPITAL SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY HOSPITAL SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY HOSPITAL SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY HOSPITAL SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY HOSPITAL SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY HOSPITAL SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY OUTPATIENT CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY OUTPATIENT CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY OUTPATIENT CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY OUTPATIENT CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY OUTPATIENT CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY OUTPATIENT CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. AMERICAS COLECTOMY PROCEDURES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 128. AMERICAS COLECTOMY PROCEDURES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 129. AMERICAS COLECTOMY PROCEDURES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 130. AMERICAS COLECTOMY PROCEDURES MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 131. AMERICAS COLECTOMY PROCEDURES MARKET SIZE, BY SURGICAL APPROACH, 2018-2024 (USD MILLION)
  • TABLE 132. AMERICAS COLECTOMY PROCEDURES MARKET SIZE, BY SURGICAL APPROACH, 2025-2032 (USD MILLION)
  • TABLE 133. AMERICAS COLECTOMY PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 134. AMERICAS COLECTOMY PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 135. AMERICAS COLECTOMY PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 136. AMERICAS COLECTOMY PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 137. AMERICAS COLECTOMY PROCEDURES MARKET SIZE, BY PARTIAL COLECTOMY, 2018-2024 (USD MILLION)
  • TABLE 138. AMERICAS COLECTOMY PROCEDURES MARKET SIZE, BY PARTIAL COLECTOMY, 2025-2032 (USD MILLION)
  • TABLE 139. AMERICAS COLECTOMY PROCEDURES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 140. AMERICAS COLECTOMY PROCEDURES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA COLECTOMY PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. NORTH AMERICA COLECTOMY PROCEDURES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. NORTH AMERICA COLECTOMY PROCEDURES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 144. NORTH AMERICA COLECTOMY PROCEDURES MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA COLECTOMY PROCEDURES MARKET SIZE, BY SURGICAL APPROACH, 2018-2024 (USD MILLION)
  • TABLE 146. NORTH AMERICA COLECTOMY PROCEDURES MARKET SIZE, BY SURGICAL APPROACH, 2025-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA COLECTOMY PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 148. NORTH AMERICA COLECTOMY PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA COLECTOMY PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 150. NORTH AMERICA COLECTOMY PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA COLECTOMY PROCEDURES MARKET SIZE, BY PARTIAL COLECTOMY, 2018-2024 (USD MILLION)
  • TABLE 152. NORTH AMERICA COLECTOMY PROCEDURES MARKET SIZE, BY PARTIAL COLECTOMY, 2025-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA COLECTOMY PROCEDURES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 154. NORTH AMERICA COLECTOMY PROCEDURES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 155. LATIN AMERICA COLECTOMY PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. LATIN AMERICA COLECTOMY PROCEDURES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. LATIN AMERICA COLECTOMY PROCEDURES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 158. LATIN AMERICA COLECTOMY PROCEDURES MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 159. LATIN AMERICA COLECTOMY PROCEDURES MARKET SIZE, BY SURGICAL APPROACH, 2018-2024 (USD MILLION)
  • TABLE 160. LATIN AMERICA COLECTOMY PROCEDURES MARKET SIZE, BY SURGICAL APPROACH, 2025-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA COLECTOMY PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 162. LATIN AMERICA COLECTOMY PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA COLECTOMY PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 164. LATIN AMERICA COLECTOMY PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA COLECTOMY PROCEDURES MARKET SIZE, BY PARTIAL COLECTOMY, 2018-2024 (USD MILLION)
  • TABLE 166. LATIN AMERICA COLECTOMY PROCEDURES MARKET SIZE, BY PARTIAL COLECTOMY, 2025-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA COLECTOMY PROCEDURES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 168. LATIN AMERICA COLECTOMY PROCEDURES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA COLECTOMY PROCEDURES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA COLECTOMY PROCEDURES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA COLECTOMY PROCEDURES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA COLECTOMY PROCEDURES MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA COLECTOMY PROCEDURES MARKET SIZE, BY SURGICAL APPROACH, 2018-2024 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA COLECTOMY PROCEDURES MARKET SIZE, BY SURGICAL APPROACH, 2025-2032 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA COLECTOMY PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA COLECTOMY PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA COLECTOMY PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA COLECTOMY PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA COLECTOMY PROCEDURES MARKET SIZE, BY PARTIAL COLECTOMY, 2018-2024 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA COLECTOMY PROCEDURES MARKET SIZE, BY PARTIAL COLECTOMY, 2025-2032 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA COLECTOMY PROCEDURES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA COLECTOMY PROCEDURES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 183. EUROPE COLECTOMY PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. EUROPE COLECTOMY PROCEDURES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. EUROPE COLECTOMY PROCEDURES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 186. EUROPE COLECTOMY PROCEDURES MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 187. EUROPE COLECTOMY PROCEDURES MARKET SIZE, BY SURGICAL APPROACH, 2018-2024 (USD MILLION)
  • TABLE 188. EUROPE COLECTOMY PROCEDURES MARKET SIZE, BY SURGICAL APPROACH, 2025-2032 (USD MILLION)
  • TABLE 189. EUROPE COLECTOMY PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 190. EUROPE COLECTOMY PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 191. EUROPE COLECTOMY PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 192. EUROPE COLECTOMY PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 193. EUROPE COLECTOMY PROCEDURES MARKET SIZE, BY PARTIAL COLECTOMY, 2018-2024 (USD MILLION)
  • TABLE 194. EUROPE COLECTOMY PROCEDURES MARKET SIZE, BY PARTIAL COLECTOMY, 2025-2032 (USD MILLION)
  • TABLE 195. EUROPE COLECTOMY PROCEDURES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 196. EUROPE COLECTOMY PROCEDURES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 197. MIDDLE EAST COLECTOMY PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. MIDDLE EAST COLECTOMY PROCEDURES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. MIDDLE EAST COLECTOMY PROCEDURES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 200. MIDDLE EAST COLECTOMY PROCEDURES MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 201. MIDDLE EAST COLECTOMY PROCEDURES MARKET SIZE, BY SURGICAL APPROACH, 2018-2024 (USD MILLION)
  • TABLE 202. MIDDLE EAST COLECTOMY PROCEDURES MARKET SIZE, BY SURGICAL APPROACH, 2025-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST COLECTOMY PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 204. MIDDLE EAST COLECTOMY PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST COLECTOMY PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 206. MIDDLE EAST COLECTOMY PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST COLECTOMY PROCEDURES MARKET SIZE, BY PARTIAL COLECTOMY, 2018-2024 (USD MILLION)
  • TABLE 208. MIDDLE EAST COLECTOMY PROCEDURES MARKET SIZE, BY PARTIAL COLECTOMY, 2025-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST COLECTOMY PROCEDURES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 210. MIDDLE EAST COLECTOMY PROCEDURES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 211. AFRICA COLECTOMY PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 212. AFRICA COLECTOMY PROCEDURES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 213. AFRICA COLECTOMY PROCEDURES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 214. AFRICA COLECTOMY PROCEDURES MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 215. AFRICA COLECTOMY PROCEDURES MARKET SIZE, BY SURGICAL APPROACH, 2018-2024 (USD MILLION)
  • TABLE 216. AFRICA COLECTOMY PROCEDURES MARKET SIZE, BY SURGICAL APPROACH, 2025-2032 (USD MILLION)
  • TABLE 217. AFRICA COLECTOMY PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 218. AFRICA COLECTOMY PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 219. AFRICA COLECTOMY PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 220. AFRICA COLECTOMY PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 221. AFRICA COLECTOMY PROCEDURES MARKET SIZE, BY PARTIAL COLECTOMY, 2018-2024 (USD MILLION)
  • TABLE 222. AFRICA COLECTOMY PROCEDURES MARKET SIZE, BY PARTIAL COLECTOMY, 2025-2032 (USD MILLION)
  • TABLE 223. AFRICA COLECTOMY PROCEDURES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 224. AFRICA COLECTOMY PROCEDURES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 225. ASIA-PACIFIC COLECTOMY PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 226. ASIA-PACIFIC COLECTOMY PROCEDURES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 227. ASIA-PACIFIC COLECTOMY PROCEDURES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 228. ASIA-PACIFIC COLECTOMY PROCEDURES MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 229. ASIA-PACIFIC COLECTOMY PROCEDURES MARKET SIZE, BY SURGICAL APPROACH, 2018-2024 (USD MILLION)
  • TABLE 230. ASIA-PACIFIC COLECTOMY PROCEDURES MARKET SIZE, BY SURGICAL APPROACH, 2025-2032 (USD MILLION)
  • TABLE 231. ASIA-PACIFIC COLECTOMY PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 232. ASIA-PACIFIC COLECTOMY PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 233. ASIA-PACIFIC COLECTOMY PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 234. ASIA-PACIFIC COLECTOMY PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 235. ASIA-PACIFIC COLECTOMY PROCEDURES MARKET SIZE, BY PARTIAL COLECTOMY, 2018-2024 (USD MILLION)
  • TABLE 236. ASIA-PACIFIC COLECTOMY PROCEDURES MARKET SIZE, BY PARTIAL COLECTOMY, 2025-2032 (USD MILLION)
  • TABLE 237. ASIA-PACIFIC COLECTOMY PROCEDURES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 238. ASIA-PACIFIC COLECTOMY PROCEDURES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 241. ASEAN COLECTOMY PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 242. ASEAN COLECTOMY PROCEDURES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 243. ASEAN COLECTOMY PROCEDURES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 244. ASEAN COLECTOMY PROCEDURES MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 245. ASEAN COLECTOMY PROCEDURES MARKET SIZE, BY SURGICAL APPROACH, 2018-2024 (USD MILLION)
  • TABLE 246. ASEAN COLECTOMY PROCEDURES MARKET SIZE, BY SURGICAL APPROACH, 2025-2032 (USD MILLION)
  • TABLE 247. ASEAN COLECTOMY PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 248. ASEAN COLECTOMY PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 249. ASEAN COLECTOMY PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 250. ASEAN COLECTOMY PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 251. ASEAN COLECTOMY PROCEDURES MARKET SIZE, BY PARTIAL COLECTOMY, 2018-2024 (USD MILLION)
  • TABLE 252. ASEAN COLECTOMY PROCEDURES MARKET SIZE, BY PARTIAL COLECTOMY, 2025-2032 (USD MILLION)
  • TABLE 253. ASEAN COLECTOMY PROCEDURES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 254. ASEAN COLECTOMY PROCEDURES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 255. GCC COLECTOMY PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 256. GCC COLECTOMY PROCEDURES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 257. GCC COLECTOMY PROCEDURES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 258. GCC COLECTOMY PROCEDURES MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 259. GCC COLECTOMY PROCEDURES MARKET SIZE, BY SURGICAL APPROACH, 2018-2024 (USD MILLION)
  • TABLE 260. GCC COLECTOMY PROCEDURES MARKET SIZE, BY SURGICAL APPROACH, 2025-2032 (USD MILLION)
  • TABLE 261. GCC COLECTOMY PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 262. GCC COLECTOMY PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 263. GCC COLECTOMY PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 264. GCC COLECTOMY PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 265. GCC COLECTOMY PROCEDURES MARKET SIZE, BY PARTIAL COLECTOMY, 2018-2024 (USD MILLION)
  • TABLE 266. GCC COLECTOMY PROCEDURES MARKET SIZE, BY PARTIAL COLECTOMY, 2025-2032 (USD MILLION)
  • TABLE 267. GCC COLECTOMY PROCEDURES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 268. GCC COLECTOMY PROCEDURES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 269. EUROPEAN UNION COLECTOMY PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 270. EUROPEAN UNION COLECTOMY PROCEDURES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 271. EUROPEAN UNION COLECTOMY PROCEDURES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 272. EUROPEAN UNION COLECTOMY PROCEDURES MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 273. EUROPEAN UNION COLECTOMY PROCEDURES MARKET SIZE, BY SURGICAL APPROACH, 2018-2024 (USD MILLION)
  • TABLE 274. EUROPEAN UNION COLECTOMY PROCEDURES MARKET SIZE, BY SURGICAL APPROACH, 2025-2032 (USD MILLION)
  • TABLE 275. EUROPEAN UNION COLECTOMY PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 276. EUROPEAN UNION COLECTOMY PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 277. EUROPEAN UNION COLECTOMY PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 278. EUROPEAN UNION COLECTOMY PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 279. EUROPEAN UNION COLECTOMY PROCEDURES MARKET SIZE, BY PARTIAL COLECTOMY, 2018-2024 (USD MILLION)
  • TABLE 280. EUROPEAN UNION COLECTOMY PROCEDURES MARKET SIZE, BY PARTIAL COLECTOMY, 2025-2032 (USD MILLION)
  • TABLE 281. EUROPEAN UNION COLECTOMY PROCEDURES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 282. EUROPEAN UNION COLECTOMY PROCEDURES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 283. BRICS COLECTOMY PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 284. BRICS COLECTOMY PROCEDURES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 285. BRICS COLECTOMY PROCEDURES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 286. BRICS COLECTOMY PROCEDURES MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 287. BRICS COLECTOMY PROCEDURES MARKET SIZE, BY SURGICAL APPROACH, 2018-2024 (USD MILLION)
  • TABLE 288. BRICS COLECTOMY PROCEDURES MARKET SIZE, BY SURGICAL APPROACH, 2025-2032 (USD MILLION)
  • TABLE 289. BRICS COLECTOMY PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 290. BRICS COLECTOMY PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 291. BRICS COLECTOMY PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 292. BRICS COLECTOMY PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 293. BRICS COLECTOMY PROCEDURES MARKET SIZE, BY PARTIAL COLECTOMY, 2018-2024 (USD MILLION)
  • TABLE 294. BRICS COLECTOMY PROCEDURES MARKET SIZE, BY PARTIAL COLECTOMY, 2025-2032 (USD MILLION)
  • TABLE 295. BRICS COLECTOMY PROCEDURES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 296. BRICS COLECTOMY PROCEDURES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 297. G7 COLECTOMY PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 298. G7 COLECTOMY PROCEDURES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 299. G7 COLECTOMY PROCEDURES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 300. G7 COLECTOMY PROCEDURES MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 301. G7 COLECTOMY PROCEDURES MARKET SIZE, BY SURGICAL APPROACH, 2018-2024 (USD MILLION)
  • TABLE 302. G7 COLECTOMY PROCEDURES MARKET SIZE, BY SURGICAL APPROACH, 2025-2032 (USD MILLION)
  • TABLE 303. G7 COLECTOMY PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 304. G7 COLECTOMY PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 305. G7 COLECTOMY PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 306. G7 COLECTOMY PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 307. G7 COLECTOMY PROCEDURES MARKET SIZE, BY PARTIAL COLECTOMY, 2018-2024 (USD MILLION)
  • TABLE 308. G7 COLECTOMY PROCEDURES MARKET SIZE, BY PARTIAL COLECTOMY, 2025-2032 (USD MILLION)
  • TABLE 309. G7 COLECTOMY PROCEDURES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 310. G7 COLECTOMY PROCEDURES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 311. NATO COLECTOMY PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 312. NATO COLECTOMY PROCEDURES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 313. NATO COLECTOMY PROCEDURES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 314. NATO COLECTOMY PROCEDURES MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 315. NATO COLECTOMY PROCEDURES MARKET SIZE, BY SURGICAL APPROACH, 2018-2024 (USD MILLION)
  • TABLE 316. NATO COLECTOMY PROCEDURES MARKET SIZE, BY SURGICAL APPROACH, 2025-2032 (USD MILLION)
  • TABLE 317. NATO COLECTOMY PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 318. NATO COLECTOMY PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 319. NATO COLECTOMY PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 320. NATO COLECTOMY PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 321. NATO COLECTOMY PROCEDURES MARKET SIZE, BY PARTIAL COLECTOMY, 2018-2024 (USD MILLION)
  • TABLE 322. NATO COLECTOMY PROCEDURES MARKET SIZE, BY PARTIAL COLECTOMY, 2025-2032 (USD MILLION)
  • TABLE 323. NATO COLECTOMY PROCEDURES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 324. NATO COLECTOMY PROCEDURES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 325. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 326. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 327. UNITED STATES COLECTOMY PROCEDURES MARKET SI